HIGHLIGHTS
- who: Liping Gu from the Shanghai General Hospital, Shanghai Jiao Tong UniversityMedical University of Silesia, Poland have published the research work: Serum spexin differed in newly diagnosed type 2 diabetes patients according to body mass index and increased with the improvement of metabolic status, in the Journal: (JOURNAL)
SUMMARY
The spexin level was significantly lower in patients with type 1 diabetes_mellitus (T1DM) and type 2 diabetes_mellitus (T2DM) than in control subjects. The previous research found that spexin levels in subjects with diabetes were much lower than those in the control group, and a . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.